These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16122680)

  • 1. Antimicrobial resistance in developing countries. Part II: strategies for containment.
    Okeke IN; Klugman KP; Bhutta ZA; Duse AG; Jenkins P; O'Brien TF; Pablos-Mendez A; Laxminarayan R
    Lancet Infect Dis; 2005 Sep; 5(9):568-80. PubMed ID: 16122680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance in developing countries. Part I: recent trends and current status.
    Okeke IN; Laxminarayan R; Bhutta ZA; Duse AG; Jenkins P; O'Brien TF; Pablos-Mendez A; Klugman KP
    Lancet Infect Dis; 2005 Aug; 5(8):481-93. PubMed ID: 16048717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance. An impending crisis.
    Mah MW; Memish ZA
    Saudi Med J; 2000 Dec; 21(12):1125-9. PubMed ID: 11360084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status and changing trends of antimicrobial resistance in Saudi Arabia.
    Akhter J; Frayha HH; Qadri SM
    J Med Liban; 2000; 48(4):227-32. PubMed ID: 11214194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.
    Aziz MA; Wright A
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S258-62. PubMed ID: 16032561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).
    Johnson DM; Stilwell MG; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):69-74. PubMed ID: 16546341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
    Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
    J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of antimicrobial resistance in resource-constrained settings - experience from five pilot projects.
    Holloway K; Mathai E; Gray A;
    Trop Med Int Health; 2011 Mar; 16(3):368-74. PubMed ID: 21138508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.
    De Cock KM; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):457-65. PubMed ID: 10383056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
    Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
    Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of poverty in antimicrobial resistance.
    Planta MB
    J Am Board Fam Med; 2007; 20(6):533-9. PubMed ID: 17954860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
    Trucchi C; Zoppi G
    J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global need for effective antibiotics-moving towards concerted action.
    Cars O; Hedin A; Heddini A
    Drug Resist Updat; 2011 Apr; 14(2):68-9. PubMed ID: 21444235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A view on antimicrobial resistance in developing countries and responsible risk factors.
    Byarugaba DK
    Int J Antimicrob Agents; 2004 Aug; 24(2):105-10. PubMed ID: 15288307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.
    Sahm DF; Brown NP; Thornsberry C; Jones ME
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):16-24. PubMed ID: 18931467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing bacterial infections and antimicrobial resistance in dialysis patients.
    Berns JS; Tokars JI
    Am J Kidney Dis; 2002 Nov; 40(5):886-98. PubMed ID: 12407632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antimicrobial resistance containment and surveillance approach--a public health tool.
    Simonsen GS; Tapsall JW; Allegranzi B; Talbot EA; Lazzari S
    Bull World Health Organ; 2004 Dec; 82(12):928-34. PubMed ID: 15654407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.